Crestor is unsafe and will be taken off the market.

The consumer group, Public Citizen, is pushing for Crestor (rosuvastatin) to be taken off the market. They say that the rates of kidney damage and rhabdomyolysis are too high.

This is all based on pre-marketing research done by the manufacturer. During these early studies some patients getting Crestor had high protein levels in the urine and 7 patients developed rhabdomyolysis.

But most of these cases occurred with the high 80 mg dose of Crestor. Trials with this dose were stopped...and the 80 mg strength was never marketed.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote